| pubmed-article:8212639 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0085143 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0022252 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0026400 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0340288 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C0022885 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8212639 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:8212639 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:8212639 | pubmed:dateCreated | 1993-11-23 | lld:pubmed |
| pubmed-article:8212639 | pubmed:abstractText | In 24 men with angina after exertion the authors assessed, using ergometry, the action of molsidomine retard and isosorbide dinitrate retard after a single dose and after tree-week administration of the drug. The authors found that 8 mg of molsidomine retard in a single dose had a somewhat more potent effect than 40 mg isosorbide dinitrate retard. After prolonged administration the effect of both drugs on haemodynamics diminished and in molsidomine a significant decline of action was observed before development of a reduced S-T segment on the ECG. After three weeks' administration the effects of both drugs were comparable. After neither drug clinically significant tolerance developed when the drug was administered every 8 hours. In the conclusion the authors discuss possible mechanisms involved in development of tolerance. | lld:pubmed |
| pubmed-article:8212639 | pubmed:language | cze | lld:pubmed |
| pubmed-article:8212639 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8212639 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8212639 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8212639 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8212639 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8212639 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8212639 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8212639 | pubmed:issn | 0042-773X | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:SemrádBB | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:RysavýFF | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:LupínekZZ | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:MeluzínJJ | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:RotreklPP | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:BocecGG | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:PirochtováII | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:VlasínováJJ | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:ManousekJJ | lld:pubmed |
| pubmed-article:8212639 | pubmed:author | pubmed-author:VlasicováII | lld:pubmed |
| pubmed-article:8212639 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8212639 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:8212639 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8212639 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:8212639 | pubmed:pagination | 856-64 | lld:pubmed |
| pubmed-article:8212639 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:meshHeading | pubmed-meshheading:8212639-... | lld:pubmed |
| pubmed-article:8212639 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8212639 | pubmed:articleTitle | [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test]. | lld:pubmed |
| pubmed-article:8212639 | pubmed:affiliation | I. klinika vnitrních chorob FNsP, Brno-Bohunice. | lld:pubmed |
| pubmed-article:8212639 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8212639 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8212639 | pubmed:publicationType | English Abstract | lld:pubmed |
